Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
4,565.00
3,890.00
3,688.00
3,070.00
3,315.00
2,751.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
4,565.00
3,890.00
3,688.00
3,070.00
3,315.00
2,751.00
Expenditure (Ex Depriciation)
Stock Adjustments
-184.00
43.00
-2.00
95.00
-353.00
-44.00
Raw Materials Consumed
2,163.00
1,705.00
1,629.00
1,407.00
1,686.00
1,167.00
Power & Fuel Cost
58.00
75.00
85.00
71.00
64.00
64.00
Employee Cost
862.00
737.00
732.00
646.00
550.00
442.00
Operating Expenses
302.00
296.00
250.00
240.00
209.00
172.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
298.00
215.00
263.00
331.00
223.00
137.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
41.00
37.00
37.00
51.00
49.00
95.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
3,762.00
3,307.00
3,258.00
3,090.00
2,681.00
2,236.00
Operating Profit (PBDIT) excl Other Income
802.00
582.00
430.00
-20.00
634.00
515.00
Other Income
58.00
39.00
90.00
131.00
51.00
53.00
Operating Profit (PBDIT)
861.00
622.00
520.00
111.00
686.00
569.00
Interest
248.00
280.00
261.00
176.00
150.00
155.00
Profit before Depriciation and Tax
612.00
341.00
259.00
-64.00
536.00
413.00
Depreciation
192.00
213.00
243.00
233.00
206.00
173.00
Profit Before Taxation & Exceptional Items
420.00
128.00
16.00
-297.00
329.00
239.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
486.00
-114.00
-286.00
-652.00
275.00
54.00
Provision for Tax
77.00
29.00
-55.00
-178.00
31.00
11.00
Profit After Tax
407.00
-89.00
54.00
-363.00
341.00
150.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
-284.00
-200.00
2.00
484.00
234.00
354.00
Profit Available for appropriations
120.00
-320.00
-218.00
24.00
488.00
403.00
Appropriations
120.00
-320.00
-218.00
24.00
488.00
403.00
Equity Dividend (%)
40.00%
25.00%
15.00%
0.00%
25.00%
140.00%
Earnings Per Share
390.55
-7.76
-22.49
-51.28
29.96
4.06
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 17.36% vs 5.47% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 37.85% vs 35.38% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -11.20% vs 7.31% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 553.17% vs -265.37% in Mar 2024
Compare Profit and Loss Results of Strides Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
4,565.00
2,622.00
1,943.00
74.10%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
4,565.00
2,622.00
1,943.00
74.10%
Expenditure (Ex Depriciation)
Stock Adjustments
-184.00
-183.00
-1.00
-0.55%
Raw Materials Consumed
2,163.00
1,327.00
836.00
63.00%
Power & Fuel Cost
58.00
40.00
18.00
45.00%
Employee Cost
862.00
350.00
512.00
146.29%
Operating Expenses
302.00
140.00
162.00
115.71%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
298.00
256.00
42.00
16.41%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
41.00
45.00
-4.00
-8.89%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
3,762.00
2,094.00
1,668.00
79.66%
Operating Profit (PBDIT) excl Other Income
802.00
528.00
274.00
51.89%
Other Income
58.00
70.00
-12.00
-17.14%
Operating Profit (PBDIT)
861.00
599.00
262.00
43.74%
Interest
248.00
11.00
237.00
2,154.55%
Profit before Depriciation and Tax
612.00
587.00
25.00
4.26%
Depreciation
192.00
83.00
109.00
131.33%
Profit Before Taxation & Exceptional Items
420.00
503.00
-83.00
-16.50%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
486.00
503.00
-17.00
-3.38%
Provision for Tax
77.00
121.00
-44.00
-36.36%
Profit After Tax
407.00
382.00
25.00
6.54%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-284.00
1,068.00
-1,352.00
-126.59%
Profit Available for appropriations
120.00
1,449.00
-1,329.00
-91.72%
Appropriations
120.00
1,449.00
-1,329.00
-91.72%
Equity Dividend (%)
40%
80%
-40.00
Earnings Per Share
390.55
8.4
382.15
4,549.40%
Profit And Loss - Net Sales
Net Sales 4,565.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.36% vs 5.47% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 802.81 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 37.85% vs 35.38% in Mar 2024
Profit And Loss - Interest
Interest 248.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -11.20% vs 7.31% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 407.57 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 553.17% vs -265.37% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
